Recurrent Ochrobactrum anthropi, Treatment, and Clinical Relevance

Ochrobactrum anthropi Infection of the Hand

Ochrobactrum anthropi is an opportunistic, low-virulence pathogen occasionally associated with human infections and found largely in immunocompromised patients and those with intravascular devices. We report the case of a healthy 70-year-old man who presented with an infection of the hand, who had no history of trauma but had been gardening for 4 months. Despite surgical debridement and empirical antibiotics, the infection could not be controlled. Cultures revealed O anthropi. Antibiotic treatment was adapted to intravenous cefepime for 15 days and the infection was finally controlled after a second surgery. Oral cotrimoxazole was continued for another 2 weeks. Ochrobactrum anthropi infection of the hand must be considered not only in immunosuppressed patients but also in healthy patients without intravascular devices. Local debridement and empiric antibiotic may be insufficient. Antibiotic therapy should follow susceptibility testing, but usually includes a broad-spectrum intravenous beta-lactam such as imipenem–cilastatin or cefepime, or oral cotrimoxazole or ciprofloxacin.

Late-onset Ochrobactrum anthropi sepsis in a preterm neonate with congenital urinary tract abnormalities

Recent trends in late-onset neonatal sepsis have revealed an increase in Gram-negative organisms as causative agents. Ochrobactrum anthropi is an emerging human pathogen that has been reported primarily in immunocompromised hosts, especially those with indwelling catheters or other medical devices. We report the occurrence of late-onset urosepsis secondary to O. anthropi in a preterm neonate with posterior urethral valves and review the salient features of the pathogen and its management.